Matt Hawkins
Advertisement
Articles by Matt Hawkins
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Modern Policy Concerns Stemming from 340B
2
Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing
3
2026 Emerging Pharma Leaders
4
Pharmaceutical Executive Daily: Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics
5